Compare T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Inverse MSTR Daily Target ETF vs Nuwellis Inc — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $10.59, while Nuwellis Inc trades at $2.92 (market cap $1.09M). The key difference: T-Rex 2X Inverse MSTR Daily Target ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| MSTZ | NUWE | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $27.92 | $527.46 |
52-Week Low | $3.50 | $2.80 |
Market Cap | — | $1.09M |
Enterprise Value | — | -$722.58K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
